The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.

Abstract:

OBJECTIVES:The objective of this paper is to perform the cross-cultural validation of the French version of the LupusPRO, a disease-targeted patient-reported outcome measure, among systemic lupus erythematosus (SLE) patients in Canada. METHODS:The French version of the LupusPRO and the MOS SF-36 were administered; demographic, clinical and serological characteristics were obtained. Disease activity (SELENA-SLEDAI and the Lupus Foundation of America definition of flare) and damage (SLICC/ACR SDI) were assessed. Physician disease activity and damage assessments were ascertained using visual analog scales. Internal consistency reliability (ICR), test-retest reliability (TRT), convergent and discriminant validity (against corresponding domains of the SF-36), criterion validity (against disease activity, damage or health status) and known group validity were tested. RESULTS:A total of 99 French-Canadian SLE patients participated (97% women, mean (SD) age 45.2 (14.5) years). The median (IQR) SELENA-SLEDAI and SDI were 3.5 (6.0) and 1.0 (2.0), respectively. The ICR of the LupusPRO domains ranged from 0.81 to 0.93 (except for lupus symptoms, procreation and coping), while TRT ranged from 0.72 to 0.95. Convergent and discriminant validity, criterion validity and known group validity against disease activity, damage and health status measures were observed. Confirmatory factor analysis showed a good fit. CONCLUSION:The LupusPRO has fair psychometric properties among French-Canadian patients with SLE.

journal_name

Lupus

journal_title

Lupus

authors

Bourré-Tessier J,Clarke AE,Kosinski M,Mikolaitis-Preuss RA,Bernatsky S,Block JA,Jolly M

doi

10.1177/0961203314543921

subject

Has Abstract

pub_date

2014-12-01 00:00:00

pages

1452-9

issue

14

eissn

0961-2033

issn

1477-0962

pii

0961203314543921

journal_volume

23

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus.

    abstract::Peripheral T cell apoptosis is upregulated in active SLE, in parallel with high expression of both membrane-bound and soluble (s) Fas. Previous studies postulated that sFas down-regulates apoptosis in vitro through its blockade of the Fas-L of cytotoxic cells. We have investigated the extent of apoptosis and sFas leve...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu250oa

    authors: Silvestris F,Grinello D,Tucci M,Cafforio P,Dammacco F

    更新日期:2003-01-01 00:00:00

  • Changing hospitalization trends for systemic lupus erythematosus and rheumatoid arthritis in England.

    abstract:OBJECTIVES:Systemic lupus erythematosus (SLE) is a chronic, multisystemic, immune-mediated disorder associated with a substantial hospitalization risk. As a comparatively rare disease, there is a sparsity of research examining the burden of hospital admission in the contemporary era. We aim to describe national trends ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319853357

    authors: Hannah J,Galloway J,Kaul A

    更新日期:2019-06-01 00:00:00

  • Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in juvenile systemic lupus erythematosus.

    abstract::Dysregulated neutrophil apoptosis may result in the development of autoimmune disease by contributing to nuclear autoantigen exposure, leading to autoantibody generation and a breakdown in immune tolerance. It has previously been shown that neutrophil apoptosis is increased in juvenile-onset systemic lupus erythematos...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203310382128

    authors: Midgley A,Mayer K,Edwards SW,Beresford MW

    更新日期:2011-01-01 00:00:00

  • Entheseal involvement in systemic lupus erythematosus: are we missing something?

    abstract::Background Musculoskeletal involvement is extremely common in patients with systemic lupus erythematosus (SLE). Continuing the research initiated in patients with inflammatory arthritis, recent studies have shown the potential role of musculoskeletal ultrasound (MSUS) in the evaluation of clinical and subclinical lupu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316662723

    authors: Di Matteo A,Satulu I,Di Carlo M,Lato V,Filippucci E,Grassi W

    更新日期:2017-03-01 00:00:00

  • Chronic intestinal pseudo-obstruction: a rare first manifestation of systemic lupus erythematosus.

    abstract::Chronic intestinal pseudo-obstruction (CIPO) is a rare clinical syndrome of ineffective intestinal motility characterised by clinical and radiological evidence of intestinal obstruction with no identifiable mechanical lesion. CIPO can either be idiopathic or secondary to a systemic disease, like systemic lupus erythem...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313492873

    authors: Khairullah S,Jasmin R,Yahya F,Cheah TE,Ng CT,Sockalingam S

    更新日期:2013-08-01 00:00:00

  • Sustained remission of lupus nephritis.

    abstract::The aim of this study was to describe the clinical course of patients with lupus nephritis (LN) who attain a sustained remission (SR) and identify predictors of SR. A retrospective study of patients with biopsy-proven LN were followed for up to 10 years. SR was defined as normal renal function, urine protein <0.5g/day...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203306lu2271oa

    authors: Barber CE,Geldenhuys L,Hanly JG

    更新日期:2006-01-01 00:00:00

  • Elucidation of the potential disease-promoting influence of IgM apoptotic cell-reactive antibodies in lupus.

    abstract::The undigested remnants of apoptosis are believed to stimulate the generation of autoantibodies in lupus. The biological properties of initiator, disease-specific IgM antibodies that specifically recognize apoptotic cells, readily detected in the sera of lupus patients, remain unclear. Apoptotic cell-reactive IgM mono...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315624023

    authors: Malik M,Arora P,Sachdeva R,Sharma L,Ramachandran VG,Pal R

    更新日期:2016-06-01 00:00:00

  • Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus.

    abstract:OBJECTIVE:The objective of this study was to analyse autoantibodies' titres modulation during belimumab treatment in 50 patients with systemic lupus erythematosus (SLE). METHODS:Sera were collected at belimumab start (T0) and every six months until the 24th month. Disease activity index (SLEDAI-2K) was analysed at eve...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319860191

    authors: Cavazzana I,Kumar R,Pozzari C,Ottaviani R,Fredi M,Piantoni S,Andreoli L,Tincani A,Franceschini F

    更新日期:2019-08-01 00:00:00

  • Monoclonal gammopathy in systemic lupus erythematosus.

    abstract::In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100410

    authors: Porcel JM,Ordi J,Tolosa C,Selva A,Castro-Salomo A,Vilardell M

    更新日期:1992-08-01 00:00:00

  • A cross-sectional study of anti-DNA antibodies in the serum and IgG and IgM fraction of healthy individuals, patients with systemic lupus erythematosus and their relatives.

    abstract::Sera from healthy individuals, relatives of lupus patients, and lupus patients with active disease and in remission were screened for IgG and IgM antibodies to ssDNA and dsDNA. The serum samples were also separated into IgG and IgM fractions which were screened for DNA reactivity at dilutions equivalent to those used ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500604

    authors: Williams WM,Isenberg DA

    更新日期:1996-12-01 00:00:00

  • Increased Incidence of juvenile onset systemic lupus erythematosus in children with atopic dermatitis.

    abstract::Herein, we investigated the risk of juvenile-onset systemic lupus erythematosus (JSLE) in children with atopic dermatitis (AD). From 2000 to 2007, 192,357 children with newly diagnosed AD and 769,428 matched non-AD controls were identified. By the end of 2008, incidences and hazard ratios (HRs) of JSLE were measured. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314543920

    authors: Wei CC,Lin CL,Tsai JD,Shen TC,Sung FC

    更新日期:2014-12-01 00:00:00

  • Outcome criteria for lupus nephritis trials: a critical overview.

    abstract::Lupus nephritis is an important cause of morbidity and mortality in patients with systemic lupus erythematosus. Traditional outcome criteria such as doubling of serum creatinine, end-stage renal disease and death have been used in controlled therapeutic trials, but are limited by their low incidence and the extended p...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920758

    authors: Boumpas DT,Balow JE

    更新日期:1998-01-01 00:00:00

  • IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.

    abstract:OBJECTIVE:To determine whether the intrathecal concentrations of cytokines/chemokines are associated with, or influenced by, serum concentrations in patients with central neuropsychiatric systemic lupus erythematosus (NPSLE), and to ascertain whether the increased production of cytokines/chemokines intrathecally relati...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316629556

    authors: Yoshio T,Okamoto H,Kurasawa K,Dei Y,Hirohata S,Minota S

    更新日期:2016-08-01 00:00:00

  • Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents.

    abstract:OBJECTIVE:The objective of this report is to assess the presence and viral load of JC polyomavirus (JCV) DNA in cerebrospinal fluid (CSF) and plasma from neuropsychiatric systemic lupus erythematosus (NPSLE) patients in comparison to controls and to investigate if different types of immunosuppressive treatments were co...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312470977

    authors: Iacobaeus E,Hopia L,Khademi M,Lundén M,Hammarin AL,Svenungsson E,Andersson M

    更新日期:2013-03-01 00:00:00

  • Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies.

    abstract::Criteria of organ-specific autoimmunity are fulfilled in a subset of patients with myocarditis/dilated cardiomyopathy (DCM). In particular, circulating heart-reactive autoantibodies are found in patients and symptom-free relatives. These autoantibodies are directed against multiple antigens, some of which are expresse...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203305lu2193oa

    authors: Caforio AL,Daliento L,Angelini A,Bottaro S,Vinci A,Dequal G,Tona F,Iliceto S,Thiene G,McKenna WJ

    更新日期:2005-01-01 00:00:00

  • Spot urine protein/creatinine ratio is unreliable estimate of 24 h proteinuria in lupus nephritis when the histological scores of activity index are higher.

    abstract:OBJECTIVES:The aim of this study was to evaluate the correlation and agreement of spot urine protein/creatinine (P/C) ratio with 24 h proteinuria in patients with lupus nephritis (LN) under different scores of activity index (AI). METHODS:In total, 90 pairs of 24 h urine and spot urine samples from 90 patients with bi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315570688

    authors: Zhang Q,Sun L,Jin L

    更新日期:2015-08-01 00:00:00

  • Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases.

    abstract::Progressive multifocal leukoencephalopathy (PML) is a rare, deadly demyelinating disease of the central nervous system, which is caused by a reactivation of the DNA polyomavirus JC and occurs in immunosuppressed individuals. So far, only 25 cases have been described in patients with SLE and none survived without antiv...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089445

    authors: Nived O,Bengtsson AA,Jönsen A,Sturfelt G

    更新日期:2008-11-01 00:00:00

  • Nervous system lupus mimics limbic encephalitis.

    abstract::A 28-year-old woman with systemic lupus erythematosus (SLE) suffered recent onset fever, headache, encephalopathy followed by severe, repeated generalized seizures. Investigations revealed limbic encephalitis. Tests for Herpes simplex encephalitis and paraneoplastic encephalomyelitis were negative. High titers anti-ri...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920523

    authors: Stübgen JP

    更新日期:1998-01-01 00:00:00

  • Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice.

    abstract::The effect of synthetic CpG-oligodeoxynucleotides (CpG-ODN) on the development of lupus nephritis during preactive phase (within seven months of age) in autoimmune lupus NZB x NZWF1 (B/WF1) mice was examined. Treatment of CpG-ODN was started at the age of 2.75 months and continued until 6.25 months. Overt disease bega...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu483oa

    authors: Hasegawa K,Hayashi T

    更新日期:2003-01-01 00:00:00

  • Accelerated atherosclerosis and coronary disease in SLE.

    abstract::Atherosclerosis may represent a significant cause of death and morbidity in patients with systemic lupus erythematosus. Coronary involvement is more premature in lupus patients. We present the case of a young woman diagnosed with SLE at the age of 20 years who had a myocardial infarction at age 29 years. We review the...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600704

    authors: Farhey Y,Hess EV

    更新日期:1997-01-01 00:00:00

  • Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.

    abstract::In examining reasons for premature atherosclerosis in systemic lupus erythematosus (SLE), we previously reported low levels of the cholesterol transport protein apolipoprotein A1 (apoA1) in these patients, and specific antibodies to purified apoA1 were identified in the sera of 5 out of 30 lupus patients. The current ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920262

    authors: Dinu AR,Merrill JT,Shen C,Antonov IV,Myones BL,Lahita RG

    更新日期:1998-01-01 00:00:00

  • Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients.

    abstract::The aim of this study is to determine prevalence, clinical significance of antiphospholipid antibodies (aPL) including anticardiolipin antibodies (aCL), anti-beta2GP1 and lupus anticoagulant (LA) in a cohort of 74 patients with primary Sjögren's syndrome (pSS) according to revised European criteria. aPL were found in ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1006oa

    authors: Fauchais AL,Lambert M,Launay D,Michon-Pasturel U,Queyrel V,Nguyen N,Hebbar M,Hachulla E,Devulder B,Hatron PY

    更新日期:2004-01-01 00:00:00

  • Association between shortened telomere length and systemic lupus erythematosus: a meta-analysis.

    abstract::Objective We aimed to evaluate the relationship between telomere length and systemic lupus erythematosus (SLE). Methods PUBMED and EMBASE databases were searched; meta-analyses were performed comparing telomere length in SLE patients and healthy controls, and on SLE patients in subgroups based on ethnicity, sample typ...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203316662721

    authors: Lee YH,Jung JH,Seo YH,Kim JH,Choi SJ,Ji JD,Song GG

    更新日期:2017-03-01 00:00:00

  • Management of antiphospholipid antibody positivity and elective orthopedic procedures.

    abstract::Current management of primary or secondary antiphospholipid antibody (aPL) syndromes with known embolic phenomena requiring anticoagulation is empiric in the setting of elective orthopedic procedures. Short-term withdrawal of warfarin with continuance of aspirin and glucocorticoid therapy was undertaken for sequential...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100311

    authors: Schnitz WM,Lister KA,McCarty GA

    更新日期:1992-05-01 00:00:00

  • Neurologic manifestations of antiphospholipid syndrome.

    abstract::Neurological involvement in antiphospholipid antibody syndrome (APS) is common, and its occurrence increases morbidity and mortality. Patients may present variable neurological involvement, such as cerebrovascular disease, cognitive dysfunction, headache, seizures, movement disorders, multiple sclerosis-like syndrome,...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203318776110

    authors: Ricarte IF,Dutra LA,Abrantes FF,Toso FF,Barsottini OGP,Silva GS,de Souza AWS,Andrade D

    更新日期:2018-08-01 00:00:00

  • Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.

    abstract:OBJECTIVE:To investigate the relationship between antimalarials (AM) and elevated muscle enzymes in systemic lupus erythematosus (SLE). PATIENTSMETHODS:325 lupus patients with abnormal creatine phosphokinase (CPK) for at least two consecutive clinic visits were enrolled; 54 patients on statins/fibrates (n = 43) and/or...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315617845

    authors: Tselios K,Gladman DD,Su J,Urowitz MB

    更新日期:2016-04-01 00:00:00

  • Altered oxidative stress markers in relation to T cells, NK cells & killer immunoglobulin receptors that are associated with disease activity in SLE patients.

    abstract::Systemic Lupus Erythematosus is an autoimmune disease with symptoms pervasive to all organ systems. It affects more females as compared to males (in the ratio 9:1). Oxidative stress plays a major role in the pathogenesis of SLE and other autoimmune diseases. In order to understand the relationship between cell specifi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320959441

    authors: Tandon A,Anupam K,Kaushal J,Gautam P,Sharma A,Bhatnagar A

    更新日期:2020-12-01 00:00:00

  • Aggravated capillary non-perfusion after intravitreal bevacizumab for macular edema secondary to systemic lupus erythematosus and anti-phospholipid syndrome.

    abstract::A 22-year-old female with history of systemic lupus erythematosus (SLE) was referred for evaluation of decreased visual acuity in her right eye. Her best-corrected visual acuity (BCVA) at the time of presentation was 20/160. Widespread cotton wool spots and macular edema were seen on biomicroscopy. Fluorescein angiogr...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311422095

    authors: Jeon S,Lee WK

    更新日期:2012-03-01 00:00:00

  • Smoking is highly associated with discoid lupus erythematosus and lupus erythematosus tumidus: analysis of 405 patients.

    abstract:BACKGROUND:Environmental factors appear to play a role in the pathogenesis of lupus erythematosus (LE). OBJECTIVE:To determine the association between cigarette smoking and various types of cutaneous LE. DESIGN:Retrospective descriptive study at a dermatology clinic of a tertiary referral hospital. METHODS:All patie...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314559630

    authors: Böckle BC,Sepp NT

    更新日期:2015-06-01 00:00:00

  • Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells.

    abstract::Previous studies in our laboratory showed a dose-dependent and hormone-specific increase in CD154 expression in T cells from females with systemic lupus erythematosus (SLE). This present study investigates if the estrogen-dependent increase in CD154 expression is due to stabilization of the messenger RNA. T cells from...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203306071314

    authors: Li X,Rider V,Kimler BF,Abdou NI

    更新日期:2006-01-01 00:00:00